Literature DB >> 6737244

Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography.

R E Wiens, D J Runser, J P Lacz, D C Dimmitt.   

Abstract

A high-performance liquid chromatographic procedure was developed for the determination of diltiazem and desacetyldiltiazem in dog plasma. Two milliliters of plasma is extracted with a hexane-2-propanol mixture. The assay uses a reverse-phase column maintained at 55 degrees C with a silica saturation column and a pellicular precolumn. The mobile phase is acetonitrile-water (50:50) at pH 6.6 with 1.5-g/L heptanesulfonic acid added as the ion-pair reagent. The procedure is sensitive to 5 ng/mL for both compounds in dog plasma and is linear up to 2000 ng/mL for diltiazem and 1000 ng/mL for desacetyldiltiazem . Preliminary dog mean plasma profiles of diltiazem and desacetyldiltiazem are presented.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6737244     DOI: 10.1002/jps.2600730525

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Performance of diltiazem tablet and multiparticulate osmotic formulations in the dog.

Authors:  S C Sutton; K Engle; R A Deeken; K E Plute; R D Shaffer
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

4.  Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.

Authors:  S J Downing; D Edwards; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.